Selective Targeting of Vascular Endothelial YAP Activity Blocks EndMT and Ameliorates Unilateral Ureteral Obstruction-Induced Kidney Fibrosis
Authors:
- 5 April 2021
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 4 (3) , 1066-1074
Abstract
Kidney fibrosis is accompanied by vascular dysfunction. Discovering new ways to ameliorate dysfunctional angiogenesis may bypass kidney fibrosis. YAP (Yes-associated protein) plays a multifaceted role during angiogenesis. Here, we found that selectively targeting YAP signaling in the endothelium ameliorates unilateral ureteral obstruction (UUO)-induced kidney fibrosis. Genetic deletion of Yap1, encoding YAP protein, in VE-cadherin+ endothelial cells inhibited endothelial-to-mesenchymal transition (EndMT) and dysfunctional angiogenesis and improved obstructive nephropathy and kidney fibrosis. Treatment with the systemic YAP inhibitor verteporfin worsened kidney fibrosis symptoms because of its lack of cell specificity. In an attempt to identify endothelial-specific YAP modulators, we found that G-protein-coupled receptor coagulation factor II receptor-like 1 (F2RL1) was highly expressed in vessels after UUO-induced kidney fibrosis. The F2RL1 peptide antagonist FSLLRY-NH2 selectively blocked YAP activity in endothelial cells and ameliorated kidney fibrosis. Thus, selective antagonization of endothelial YAP activity might bypass kidney fibrosis and provide new avenues for the design of antifibrotic therapies.Keywords
Funding Information
- Science and Technology Department of Sichuan Province (2020JDRC0113)
- National Natural Science Foundation of China (22077106, 81601213, 81700542)
- Science and Technology Strategic Cooperation Project of Luzhou Municipal People's Government-Southwest Medical University (2019LZXNYDJ31)
- Joint Project of Southwest Medical University and Affiliated Traditional Medicine Hospital of Southwest Medical University (2017XYLH-028, 2018XYLH-022)
- Luzhou Municipal-Southwest Medical University Joint Special Grant for the Introduction of High-Level Talents (Lan Hui-Yao Team)
- Luzhou-Southwest Medical Joint Platform Project (2018LZXNYD-PT03)
- Natural science project of Southwest Medical University (2020ZRQNA036)
This publication has 28 references indexed in Scilit:
- Subcellular localization of coagulation factor II receptor-like 1 in neurons governs angiogenesisNature Medicine, 2014
- TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft RemodelingScience Translational Medicine, 2014
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentNature Reviews Drug Discovery, 2013
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor SignalingCell, 2012
- Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAPGenes & Development, 2012
- GPCR expression in tissues and cells: Are the optimal receptors being used as drug targets?British Journal of Pharmacology, 2012
- Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic NephropathyDiabetes, 2010
- Endothelial-Myofibroblast Transition Contributes to the Early Development of Diabetic Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic MiceThe American Journal of Pathology, 2009
- Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal TransitionJournal of the American Society of Nephrology, 2008
- Animal Models of Renal Fibrosis2005